Mental disorders like depression and anxiety are characterized by a variety of different symptoms, and individuals receiving the same diagnosis may experience different combinations of those symptoms.

For decades, one of the greatest challenges to treating neurological disorders like attention-deficit/hyperactivity disorder is that its symptoms often resemble those of several other conditions.

GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness ...

Researchers recently discovered that eight different psychiatric conditions share a common genetic basis. A new study has now honed in on some of those shared genetic variants to understand their ...

Social media has transformed the way people interact with each other and the world. Across the globe, researchers have documented political, social, emotional, and even health implications related to ...

A Swedish national cohort study shows some GLP-1s — semaglutide in particular — are associated with reduced risk of psychiatric decline in patients with depression or anxiety.

Could hyperbaric oxygen treat PTSD, depression, and anxiety? New evidence suggests that this treatment may rewire the ...

Nonprofit Project Blackbird uses film and discussion to help students open up about mental health, eating disorders and ...